NBP
NovaBridge Biosciences
1.40$
-1.4%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +377.4% | -44.2% | +5,042.2% | -94.3% | -112.2% | – | -100.0% | – | |
| – | – | – | – | – | -41.3% | -100.0% | – | – | |
| – | +365.4% | -44.2% | +5,042.2% | -97.3% | -125.7% | – | – | – | |
| – | +59.5% | +97.3% | +17.2% | -80.7% | -18.3% | -26.5% | +38.9% | -94.3% | |
| – | +161.0% | +885.9% | -38.5% | +123.6% | -77.8% | -68.0% | +238.7% | -97.9% | |
| – | +68.3% | +203.6% | -7.2% | +52.3% | -83.2% | +45.1% | -27.2% | -96.4% | |
| – | – | – | – | -1,431.4% | – | – | – | – | |
| – | +96.7% | -74.9% | -65.7% | -100.0% | – | +7,708.0% | – | – | |
| – | – | – | – | -582.7% | – | – | – | – | |
| – | – | – | – | -104.0% | – | – | – | – | |
| – | – | – | – | -595.1% | – | – | – | – | |
| – | – | – | – | -1,322.4% | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.